Physician profile
Isha Mannering
NPI 1124343637
$450.90
in general payments reported to CMS, 2019-2025
15 companies · $56.44 in 2025
The $56.44 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.48 · 2020: $31.43 · 2021: $54.44 · 2022: $23.08 · 2023: $153 · 2024: $71.89 · 2025: $56.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $92.97 | 2019-2023 | Bexsero |
| Kowa Pharmaceuticals America, INC. | $50.89 | 2024-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $47.00 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $34.40 | 2021-2023 | Rotateq, Vaxneuvance, Gardasil 9 |
| Cranial Technologies, INC | $32.69 | 2023 | Doc Band |
| Ironshore Pharmaceuticals INC. | $28.73 | 2023 | Jornay Pm |
| Genentech USA, INC. | $27.42 | 2019-2020 | |
| Sanofi Pasteur INC. | $23.08 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.30 | 2023 | Flumist Quadrivalent |
| Corium, LLC | $18.51 | 2023 | Azstarys |
| Abbvie INC. | $18.28 | 2019 | |
| Verrica Pharmaceuticals INC. | $15.76 | 2024 | Ycanth |
| Seqirus USA INC | $14.68 | 2024 | Flucelvax |
| Neos Therapeutics, LP | $13.30 | 2021 | |
| Mission Pharmacal Company | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isha Mannering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.